Business
Statement re Media Speculation
Statement re Media Speculation.
About this update from Niox Group Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION, INCLUDING THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER RESTRICTED JURISDICTION (TOGETHER, THE \"RESTRICTED JURISDICTIONS\").\nTHIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE \"CODE\") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \nFOR IMMEDIATE RELEASE \n20 March 2025\n \nNIOX Group Plc\nStatement regarding media speculation\nThe Board of NIOX Group plc (\"NIOX\", the \"Company\" or the \"Group\"; AIM: NIOX), a medical device company focused on point of care asthma diagnosis, monitoring and management, notes the recent media speculation and confirms that on 6 March 2025, it received a revised proposal from Keensight Capital on behalf of funds managed or advised by it (\"Keensight\") regarding a possible cash offer to acquire the entire issued and to be issued ordinary share capital of NIOX (the \"Proposal\") at an offer price of 81 pence per NIOX share (inclusive of any future dividend that may be paid after the date of the Proposal).\nThe Proposal follows a previous unsolicited approach by Keensight to acquire NIOX on 20 February 2025 at an offer price of 78 pence per NIOX share (inclusive of any future dividend that may be paid after the date of the Proposal).\nThe Proposal is subject to the satisfaction or waiver by Keensight of a number of pre-conditions, including the completion of satisfa...